coteauBeta Get App
CYPH

CYPH

Cypherpunk Technologies Inc.
$3.34
+18.68% Oct 21 close
Financial Services Compare
-22%+155%+333%+510%+688%Oct 2025Oct 2026Apr 2026
CYPHSPY
1W
+27.3%
1M
-1.9%
3M
+396.3%
6M
+289.6%
YTD
+187.5%
1Y
+586.2%

Live chart

Loading live chart…

What they do

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01.

Financial Services · Asset Management

For information only · Important disclosures

Grades vs sector

No sector grades for CYPH yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
Winklevoss Twins-Backed Cypherpunk Says Zcash Mining Is 'Nowhere Close' To Bitcoin, AI — Sees $10K Potential
Stocktwits · Oct 12
Winklevoss Twins To Launch New Zcash ETF
CryptoProwl · Oct 07
The Winklevoss Twins Plan to Invest $100 Million in the Coin That Outperformed Bitcoin
24/7 Wall St. · Oct 06
Another Zcash ETF Is Coming: Winklevoss Twins File for 'WINK'
decrypt · Oct 06
Winklevoss Zcash ETF Could Become the Second U.S. Spot ZEC Fund After Grayscale’s ZCSH
Unchained · Oct 06

Key stats

Market value$358.9M
P/E (last 12 months)5.3
P/E (next 12 months, estimated)-37.0
52-week range$0.39 – $4.19
Dividend yieldNo dividend
Average analyst price target$4.90 (+47%)
Valuation and fundamentals

Valuation & fundamentals

Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
•Piotroski F-score4/9

Discounted cash flow

Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (FY to 2021-12-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.86 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $-0.09 vs trailing $0.63 (-114% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin
–
Operating margin
-1185.0%
FCF margin
-1410.5%
Net margin
-58.5%
Return on equity
-0.6%
Return on invested capital
-8.8%
Net debt / EBITDA
–
Current ratio
79.2×
Interest cover
-740.6×
Cash conversion (OCF/NI)
–
Piotroski F-score 4/9 · last two fiscal years
✓ Positive net income✗ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✗ Gross margin improved✗ Asset turnover improved

Analysts

Mean target
$5
+47%
Analysts
1
None
Range
$5–$5
low – high

Annual history

FYRevenueNet incomeFree cash flow
2021$1.5M$-40.6M$-35.2M
2020$1.5M$-27.5M$-26.0M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.

Earnings

Next report: 2026-11-11 · before open · EPS est -0.02
24-0824-1125-0325-0525-0825-1126-0526-08-0.520.00
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-12-0.03-0.02+32.3%
2026-05-14-0.12-0.46-283.3%
2025-11-12-0.24-0.08+66.7%
2025-08-14-0.29-0.40-37.9%
2025-05-13-0.38-0.37+2.6%
2025-03-26-0.36-0.37-2.8%
2024-11-13-0.47-0.44+7.0%
2024-08-12-0.40-0.52-28.4%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$0–
2026-03-31$0–
2025-12-31$0–
2025-09-30$0–
2025-06-30$0–
Analyst actions
Cantor Fitzgerald
2026-09-10 · main
Overweight → Overweight
PT $5
Cantor Fitzgerald
2026-08-27 · reit
Overweight → Overweight
PT $2
Cantor Fitzgerald
2026-08-19 · main
Overweight → Overweight
PT $2
Cantor Fitzgerald
2026-07-01 · init
→ Overweight
PT $1

Stats refreshed 2026-10-21 17:34:49 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026